Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Walsh

Showing results (51-60 of 86) with videos related to

Pageof 9
Sort By:
Future Oncology (London, England)|March 6, 2025
Matching-adjusted indirect comparison of talazoparib plus enzalutamide versus abiraterone acetate and docetaxel in mCRPCElena Castro, Di Wang, Sarah Walsh, et al.
Prostate Cancer and Prostatic Diseases|December 7, 2024
Talazoparib plus enzalutamide versus olaparib plus abiraterone acetate and niraparib plus abiraterone acetate for metastatic castration-resistant prostate cancer: a matching-adjusted indirect comparisonElena Castro, Di Wang, Sarah Walsh, et al.
Journal of Physical Activity & Health|August 12, 2020
Evidence on Physical Activity and the Prevention of Frailty and Sarcopenia Among Older People: A Systematic Review to Inform the World Health Organization Physical Activity GuidelinesJuliana S Oliveira, Marina B Pinheiro, Nicola Fairhall, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 30, 2023
Indirect treatment comparisons of the gene therapy etranacogene dezaparvovec versus extended half-life factor IX therapies for severe or moderately severe haemophilia BRobert Klamroth, Ashley Bonner, Keith Gomez, et al.
European Journal of Haematology|June 20, 2002
Somatic hypermutation and V(H) gene usage in mantle cell lymphomaMia Thorsélius, Sarah Walsh, Inger Eriksson, et al.
JCO Oncology Practice|September 11, 2020
Case of Fatal Immune-Related Skin Toxicity From Sequential Use of Osimertinib After Pembrolizumab: Lessons for Drug Sequencing in Never-Smoking Non-Small-Cell Lung CancerWanyuan Cui, Chantal Cotter, Katherina Bernadette Sreter, et al.
Journal of Neuropathology and Experimental Neurology|February 20, 2009
Locally synthesized calcitonin gene-related Peptide has a critical role in peripheral nerve regenerationCory C Toth, Dianna Willis, Jeffery L Twiss, et al.
Chembiochem : a European Journal of Chemical Biology|August 6, 2020
Development of Gene-Targeted Polypyridyl Triplex-Forming Oligonucleotide HybridsNicolò Zuin Fantoni, Bríonna McGorman, Zara Molphy, et al.
Journal of Comparative Effectiveness Research|June 2, 2023
Comparative efficacy of therapies for relapsing multiple sclerosis: a systematic review and network meta-analysisImtiaz A Samjoo, Christopher Drudge, Sarah Walsh, et al.
Biorxiv : the Preprint Server for Biology|April 27, 2026
Astrocytes mediate the pro-cognitive value of α7nAChRs and of α7nAChR-targeting therapeuticsYifan Wu, Michaela Tolman, Yanchao Dai, et al.
Pageof 9

Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
Future Oncology (London, England)|March 6, 2025
Matching-adjusted indirect comparison of talazoparib plus enzalutamide versus abiraterone acetate and docetaxel in mCRPCElena Castro, Di Wang, Sarah Walsh, et al.
Prostate Cancer and Prostatic Diseases|December 7, 2024
Talazoparib plus enzalutamide versus olaparib plus abiraterone acetate and niraparib plus abiraterone acetate for metastatic castration-resistant prostate cancer: a matching-adjusted indirect comparisonElena Castro, Di Wang, Sarah Walsh, et al.
Journal of Physical Activity & Health|August 12, 2020
Evidence on Physical Activity and the Prevention of Frailty and Sarcopenia Among Older People: A Systematic Review to Inform the World Health Organization Physical Activity GuidelinesJuliana S Oliveira, Marina B Pinheiro, Nicola Fairhall, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 30, 2023
Indirect treatment comparisons of the gene therapy etranacogene dezaparvovec versus extended half-life factor IX therapies for severe or moderately severe haemophilia BRobert Klamroth, Ashley Bonner, Keith Gomez, et al.
European Journal of Haematology|June 20, 2002
Somatic hypermutation and V(H) gene usage in mantle cell lymphomaMia Thorsélius, Sarah Walsh, Inger Eriksson, et al.
JCO Oncology Practice|September 11, 2020
Case of Fatal Immune-Related Skin Toxicity From Sequential Use of Osimertinib After Pembrolizumab: Lessons for Drug Sequencing in Never-Smoking Non-Small-Cell Lung CancerWanyuan Cui, Chantal Cotter, Katherina Bernadette Sreter, et al.
Journal of Neuropathology and Experimental Neurology|February 20, 2009
Locally synthesized calcitonin gene-related Peptide has a critical role in peripheral nerve regenerationCory C Toth, Dianna Willis, Jeffery L Twiss, et al.
Chembiochem : a European Journal of Chemical Biology|August 6, 2020
Development of Gene-Targeted Polypyridyl Triplex-Forming Oligonucleotide HybridsNicolò Zuin Fantoni, Bríonna McGorman, Zara Molphy, et al.
Journal of Comparative Effectiveness Research|June 2, 2023
Comparative efficacy of therapies for relapsing multiple sclerosis: a systematic review and network meta-analysisImtiaz A Samjoo, Christopher Drudge, Sarah Walsh, et al.
Biorxiv : the Preprint Server for Biology|April 27, 2026
Astrocytes mediate the pro-cognitive value of α7nAChRs and of α7nAChR-targeting therapeuticsYifan Wu, Michaela Tolman, Yanchao Dai, et al.
Pageof 9